The role of aggressive medical therapy along with early surgical intervention in the cure of Brucella endocarditis.
Timing of surgical intervention in Brucella endocarditis remains controversial. In this report, we review our experience in an attempt to collect some information on the best approach for this entity. From June 1992 to December 1996, 5 male patients between the ages of 20 and 35 years with Brucella endocarditis were operated on in our centre. Three of them had native valve endocarditis (NVE) and 2 with prosthetic valve endocarditis (PVE). All patients belonged to New York Heart Association (NYHA) class III-IV. All had developed anti Brucella antibodies with serum agglutination titres of > 320 and the sera tested from 3 patients were Enzyme Linked Immunosorbent Assay (ELISA) positive for anti-Brucella IgM and/or IgG antibodies. In 3 cases 2D-echocardiography showed large vegetation on the affected valve. Blood cultures were positive in 4 patients, 2 of them (one each of NVE and PVE) had the valve material culture positive for Brucella. All cases were treated with a combination of doxycycline, refampicine and gentamicin before surgery. Major indication for surgical intervention was severe haemodynamic instability which developed during the course of antibiotic therapy either early (3 cases) or late (2 cases). All patients became asymptomatic at the end of 7 days postoperatively. On the follow-up for a period of 8-51 months, all patients were in NYHA class I-II without evidence of recurrence of infection. These data suggest that in either NVE or PVE Brucella, medical therapy alone may not be sufficient due to the eventual haemodynamic deterioration secondary to valve tissue destruction or dysfunction of the prosthetic valve caused by the infective process. Therefore, a combination of aggressive medical therapy with multiple bactericidal antibiotics and early surgical intervention may result in a successful outcome, but further studies are needed to reach a reliable conclusion.
Uddin
M J
MJ
Department of Cardiac Surgery, Chest Diseases Hospital, Ibn Sina Hospital, P.O. Box 4082, Safat-13041, Kuwait.
Sanyal
S C
SC
Mustafa
A S
AS
Mokaddas
E M
EM
Salama
A L
AL
Cherian
G
G
Mounjaeed
M
M
Shuhaiber
H
H
D000328:Adult; D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial / Q000032:analysis; D002002:Brucella / Q000276:immunology / Q000302:isolation & purification; D002006:Brucellosis / Q000382:microbiology / Q000628:therapy*; D013504:Cardiovascular Surgical Procedures; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging / Q000628:therapy*; D004797:Enzyme-Linked Immunosorbent Assay; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000000981:diagnostic imaging / Q000382:microbiology / Q000628:therapy*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000000981:diagnostic imaging / Q000628:therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial